María José Terol Casterá

4PUBLICATIONS
38CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2025
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.

Martin Hutchings, Anna Sureda, Francesc Bosch

|Aug 18, 2025
Consensus on the Diagnosis and Management of Patients with Breakthrough Cancer Pain (BTcP), Including Procedural BTcP: DIOPRO Study.

María Dolores López Alarcón, Francisco Villegas Estévez, Jorge Contreras Martínez

|Jul 11, 2024
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma.

Thomas Witzig, Lubomir Sokol, Won Seog Kim

|Jun 20, 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group.

Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco

Pageof 1

Frequent Collaborators

2 joint publications

Alejandro Martín García-Sancho

1 joint publications

Beatriz Rey-Búa

1 joint publications

Carlos Grande

1 joint publications

José J Sánchez Blanco